The U.S. Department of Agriculture has approved TruCan™ Ultra CIV H3N2/H3N8, a canine influenza vaccine designed to provide broad respiratory disease protection. The approval of this CIV vaccine completes Elanco’s Tru Portfolio of comfortable and convenient combination vaccines made with PureFil™ Technology, an exclusive process for creating highly purified vaccines designed to reduce adverse reactions and deliver better experiences.
The vaccine is now available for pre-order and will ship within the next 30 business days.
Source: Elanco, July 9, 2025. Link. Elanco’s Tru Vaccine line is the first vaccine line recommended by Fear Free®.